68Ga-DOTA-Bombesin

DOTA-Bombesin radiopharmaceutical labeled with Gallium-68

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for 68Ga-DOTA-Bombesin, covering 2017-04-11 to 2017-04-11. Get the full timeline:

Most recent: Clinical Trial Update: 68Ga-DOTA-Bombesin PET/MRI in Imaging Patients With Prostate Cancer [Phase 2]